- Investing Ideas
- /
- U.S. Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Strong Past Earnings Growth, P/E Ratio Below 20
Results
131
9 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
131 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BRK.A | US$682,500.00 | -0.5% | 25.8% | US$968.6b | US$746,755.25 | PE9.2x | E-41.6% | n/a | Diversified Financials | ||
QCOM | US$152.89 | -3.6% | 6.6% | US$167.1b | US$204.70 | PE16.8x | E7.1% | 2.2% | Semiconductors | ||
CB | US$273.20 | -1.0% | 23.7% | US$110.1b | US$300.80 | PE11x | E1.0% | 1.3% | Insurance | ||
JD | US$35.64 | -4.4% | 29.2% | US$52.1b | US$48.76 | PE10.8x | E8.4% | 2.0% | Retail | ||
BKR | US$40.32 | -4.3% | 18.2% | US$39.4b | US$46.68 | PE17.8x | E10.5% | 2.1% | Energy | ||
HIG | US$109.47 | -2.3% | 37.6% | US$31.0b | US$129.29 | PE10.5x | E7.7% | 1.9% | Insurance | ||
CNC | US$59.58 | 0.3% | -18.8% | US$30.1b | US$79.39 | PE9.8x | E3.4% | n/a | Healthcare | ||
HPE | US$21.61 | -1.0% | 26.4% | US$27.5b | US$24.31 | PE11.1x | E0.6% | 2.4% | Tech | ||
TROW | US$116.12 | -2.9% | 7.6% | US$25.1b | US$115.50 | PE12.6x | E0.3% | 4.3% | Diversified Financials | ||
SYF | US$65.45 | -3.8% | 72.5% | US$25.0b | US$71.01 | PE8.2x | E-5.6% | 1.5% | Diversified Financials | ||
BF.B New | US$41.28 | -8.2% | -28.5% | US$19.4b | US$47.78 | PE19.4x | E3.7% | 2.2% | Food, Beverage & Tobacco | ||
KSPI | US$98.70 | -6.9% | 9.7% | US$18.6b | US$133.84 | PE10.1x | E23.7% | 6.6% | Diversified Financials | ||
L | US$83.19 | -1.2% | 20.9% | US$17.8b | n/a | PE10.8x | n/a | 0.3% | Insurance | ||
CSL New | US$378.27 | -9.9% | 21.2% | US$17.1b | US$486.67 | PE19.2x | E6.3% | 1.1% | Capital Goods | ||
MOH | US$294.73 | -2.7% | -17.8% | US$16.8b | US$364.63 | PE14.7x | E14.7% | n/a | Healthcare | ||
UTHR | US$359.58 | -0.6% | 64.2% | US$16.1b | US$393.74 | PE14.5x | E9.7% | n/a | Pharmaceuticals & Biotech | ||
EG | US$356.64 | -1.7% | 0.8% | US$15.0b | US$428.75 | PE5.6x | E9.4% | 2.2% | Insurance | ||
UNM | US$72.01 | -2.5% | 60.2% | US$13.0b | US$76.73 | PE7.5x | E-3.9% | 2.3% | Insurance | ||
CNA | US$48.21 | -1.3% | 14.7% | US$12.9b | US$50.00 | PE10x | E15.8% | 7.8% | Insurance | ||
NVT New | US$69.55 | -7.3% | 17.8% | US$11.5b | US$84.80 | PE19.9x | E0.6% | 1.1% | Capital Goods | ||
AIZ | US$212.27 | -2.6% | 27.9% | US$10.7b | US$233.20 | PE14.7x | E14.5% | 1.4% | Insurance | ||
SEIC New | US$82.75 | -3.6% | 28.1% | US$10.5b | US$80.80 | PE19.5x | E7.0% | 1.2% | Diversified Financials | ||
SF | US$104.49 | -5.5% | 52.4% | US$10.5b | US$112.75 | PE17.5x | E13.1% | 1.6% | Diversified Financials | ||
TTC New | US$81.48 | -7.7% | -17.5% | US$8.2b | US$93.60 | PE19.7x | E5.8% | 1.9% | Capital Goods |